Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …

Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

Importance Passive antibody transfer is a longstanding treatment strategy for infectious
diseases that involve the respiratory system. In this context, human convalescent plasma has …

Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …

Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…

Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19. …

In humans, β-adrenergic receptor activation causes a substantial portion of hypoxic vasodilation
in skeletal muscle at rest and during forearm exercise. Recent evidence suggests that β-…

Key points Theoretical models suggest there is no benefit of high affinity haemoglobin to
preserve maximal oxygen uptake in acute hypoxia but the comparative biology literature has …

Key points Haemoglobin affinity is an integral concept in exercise physiology that impacts
oxygen uptake, delivery and consumption. How chronic alterations in haemoglobin affinity …